Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Hepion Pharmaceuticals, Inc. (CTRV)
|
Add to portfolio |
|
|
|
| Price: |
$1.71
| | Metrics |
| OS: |
3.84
|
M
| |
|
|
| Market cap: |
$6.56
|
M
| |
|
|
|
Net cash:
|
$30.5
|
M
| |
$7.95
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 | Jun-30-14 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | 0.0 | | | | | | | |
| Research and development | | 12.0 | 3.2 | 7.6 | 13.7 | 15.0 | 8.4 | 0.3 |
| General and administrative | 0.0 | 8.1 | 4.6 | 7.0 | 7.4 | 5.8 | 5.6 | 1.4 |
| EBIT | 0.0 | -20.1 | -7.8 | -14.6 | -21.0 | -20.8 | -14.0 | -1.7 |
| Pre-tax income | 0.0 | -20.3 | -7.9 | -10.0 | -16.8 | -17.0 | -14.3 | -5.3 |
| Income taxes | 0.0 | 0.0 | -0.9 | -0.5 | -1.9 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 11.4% | 5.4% | 11.4% | 0.0% | 0.0% | 0.0% |
| Net income | 0.0 | -20.4 | -12.5 | -17.9 | -14.9 | -17.0 | -14.3 | -5.3 |
| |
| Diluted EPS | | ($2.10) | ($6.11) | ($97.35) | ($2.04) | ($0.63) | ($0.66) | ($0.41) |
| Shares outstanding (diluted) | | 9.7 | 2.0 | 0.2 | 7.3 | 27.1 | 21.8 | 12.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|